Drawing for HY2CARE

USPTO serial 79334421

HY2CARE

Reviewed by CopyMark Law Group

Reg. 7095412Status 700Registered
Filing date
Status date
Registration date
Jul 4, 2023
Examiner
BROWN, TINA
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with HY2CARE?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Bradley M. Stohry

Bradley M. Stohry Reichel Stohry Dean LLP6151 Central AveIndianapolis, IN 46220United States

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical compositions for cartilage repair and treatments; pharmaceutical compositions for pain management and inflammation reduction; pharmaceutical compositions for bone repair; pharmaceutical gels for cartilage repair and treatments; pharmaceutical gels for pain management and inflammation reduction; pharmaceutical gels for bone repair; injectable pharmaceuticals for cartilage repair and treatments; injectable pharmaceuticals for pain management and inflammation reduction; injectable pharmaceuticals for bone repair; pharmaceutical products containing liquid polymers for cartilage repair and treatments; pharmaceutical products containing liquid polymers for pain management and inflammation reduction; pharmaceutical products containing liquid polymers for bone repair; pharmaceutical products containing hydrogels for cartilage repair and treatments; pharmaceutical products containing hydrogels for pain management and inflammation reduction; pharmaceutical products containing hydrogels for bone repair; advanced therapy medicinal products for cartilage repair and treatments; advanced therapy medicinal products for pain management and inflammation reduction; advanced therapy medicinal products for bone repair; advanced therapy medicinal products containing liquid polymers for cartilage repair and treatments; advanced therapy medicinal products containing liquid polymers for pain management and inflammation reduction; advanced therapy medicinal products containing liquid polymers for bone repair; advanced therapy medicinal products containing hydrogels for cartilage repair and treatments; advanced therapy medicinal products containing hydrogels for pain management and inflammation reduction; advanced therapy medicinal products containing hydrogels for bone repair; biological tissue cultures for medical purposes; biological tissue cultures for veterinary purposes; medicated hydrogels for cartilage repair and treatments; medicated hydrogels for pain management and inflammation reduction; medicated hydrogels for bone repair; medicated hydrogels resorbable by the human and animal body for cartilage repair and treatments; medicated hydrogels resorbable by the human and animal body for pain management and inflammation reduction; medicated hydrogels resorbable by the human and animal body for bone repair; pharmaceutical products for cartilage repair and treatments; pharmaceutical products for pain management and inflammation reduction; pharmaceutical products for bone repair; injectable dermal fillers; dental fillers, namely, teeth filling material; surgical glues and sealantsACTIVE—
010Medical devices, namely, injection needles; medical devices, namely, syringes; medical devices for injection of liquid components in the human and animal body, namely, injection needles; medical devices for injection of liquid polymers in the human and animal body, namely, injection needles; medical devices for injection of hydrogels in the human and animal body, namely, injection needles; medical devices for supply of pharmaceutical products for cartilage repair to the human and animal body, namely, injection instruments with needles; medical devices for supply of pharmaceutical products for bone repair to the human and animal body, namely, injection instruments with needles; medical devices for supply of dermal fillers to the human body, namely, injection needles; medical devices for supply of dental fillers to the human and animal body, namely, injection needles; medical devices for supply of dental fillers to the human and animal body, namely, syringes; medical devices for application of surgical glues and sealants to the human and animal body; diagnostic apparatus for medical purposes, namely, ultrasound diagnostic apparatus; diagnostic apparatus for medical purposes, namely, X-ray diagnostic apparatus; cell culture instruments for medical use, namely, cell culture chambersACTIVE—
044Medical services, namely, cartilage repair in the human body; medical services, namely, pain management and inflammation reduction in the human body; medical services, namely, bone repair in the human body; dermatology services for the human body; dentistry services for the human body; surgical treatment services, namely, surgery of the human body; medical services for the diagnosis of conditions of the human body; drug screening of the human body for medical purposes; drug screening of the human body for medical purposes involving application of liquid polymers; drug screening of the human body for medical purposes involving application of hydrogelsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 24, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Jun 6, 2025NREPNEW REPRESENTATIVE AT IB RECEIVED—
Apr 21, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 21, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 21, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Apr 21, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 21, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Oct 31, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Oct 5, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Oct 5, 2023FIMPFINAL DISPOSITION PROCESSED—
Oct 4, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Jul 4, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Jul 4, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 19, 2023GPNXNOTIFICATION PROCESSED BY IB—
Apr 18, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 18, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Mar 29, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Mar 29, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Mar 29, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 12, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 31, 2023TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 30, 2023CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 30, 2023TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 23, 2022RFNPREFUSAL PROCESSED BY IB—
Aug 4, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Aug 3, 2022RFRRREFUSAL PROCESSED BY MPU—
Aug 2, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Aug 1, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 27, 2022DOCKASSIGNED TO EXAMINER—
Apr 8, 2022ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Mar 1, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Feb 25, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 24, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance